240 related articles for article (PubMed ID: 28368674)
1. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
Diaz C; Guzmán J; Jiménez VA; Alderete JB
Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
[TBL] [Abstract][Full Text] [Related]
2. Association of Methotrexate with Native and PEGylated PAMAM-G4 Dendrimers: Effect of the PEGylation Degree on the Drug-Loading Capacity and Preferential Binding Sites.
Barraza LF; Jiménez VA; Alderete JB
J Phys Chem B; 2017 Jan; 121(1):4-12. PubMed ID: 27982591
[TBL] [Abstract][Full Text] [Related]
3. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
4. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
5. Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer-risperidone complexes.
Prieto MJ; Temprana CF; del Río Zabala NE; Marotta CH; Alonso Sdel V
Eur J Med Chem; 2011 Mar; 46(3):845-50. PubMed ID: 21251731
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation.
Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U
Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027
[TBL] [Abstract][Full Text] [Related]
7. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex.
Jiang YY; Tang GT; Zhang LH; Kong SY; Zhu SJ; Pei YY
J Drug Target; 2010 Jun; 18(5):389-403. PubMed ID: 20055559
[TBL] [Abstract][Full Text] [Related]
8. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.
Kim Y; Klutz AM; Jacobson KA
Bioconjug Chem; 2008 Aug; 19(8):1660-72. PubMed ID: 18610944
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers.
Gürbüz MU; Öztürk K; Ertürk AS; Yoyen-Ermis D; Esendagli G; Çalış S; Tülü M
J Biomater Sci Polym Ed; 2016 Nov; 27(16):1645-58. PubMed ID: 27534577
[TBL] [Abstract][Full Text] [Related]
10. Dendrimers bind antioxidant polyphenols and cisplatin drug.
Abderrezak A; Bourassa P; Mandeville JS; Sedaghat-Herati R; Tajmir-Riahi HA
PLoS One; 2012; 7(3):e33102. PubMed ID: 22427960
[TBL] [Abstract][Full Text] [Related]
11. Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin.
Huang X; Wu Z; Gao W; Chen Q; Yu B
Drug Dev Ind Pharm; 2011 Apr; 37(4):419-27. PubMed ID: 20942611
[TBL] [Abstract][Full Text] [Related]
12. The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.
Shen W; van Dongen MA; Han Y; Yu M; Li Y; Liu G; Banaszak Holl MM; Qi R
Eur J Pharm Biopharm; 2014 Nov; 88(3):658-63. PubMed ID: 25083608
[TBL] [Abstract][Full Text] [Related]
13. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
14. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells.
Ayatollahi S; Hashemi M; Oskuee RK; Salmasi Z; Mokhtarzadeh A; Alibolandi M; Abnous K; Ramezani M
J Biomater Appl; 2015 Nov; 30(5):632-48. PubMed ID: 26265706
[TBL] [Abstract][Full Text] [Related]
16. PEGylated PAMAM dendrimers loading oxaliplatin with prolonged release and high payload without burst effect.
Ho MN; Bach LG; Nguyen DH; Nguyen CH; Nguyen CK; Tran NQ; Nguyen NV; Hoang Thi TT
Biopolymers; 2019 Jul; 110(7):e23272. PubMed ID: 30897210
[TBL] [Abstract][Full Text] [Related]
17. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
18. PAMAM-grafted TiO2 nanotubes as novel versatile materials for drug delivery applications.
Torres CC; Campos CH; Diáz C; Jiménez VA; Vidal F; Guzmán L; Alderete JB
Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():164-71. PubMed ID: 27157739
[TBL] [Abstract][Full Text] [Related]
19. Ultrafast in situ forming poly(ethylene glycol)-poly(amido amine) hydrogels with tunable drug release properties via controllable degradation rates.
Buwalda SJ; Bethry A; Hunger S; Kandoussi S; Coudane J; Nottelet B
Eur J Pharm Biopharm; 2019 Jun; 139():232-239. PubMed ID: 30954658
[TBL] [Abstract][Full Text] [Related]
20. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
